Metabolic disturbances as a factor of the pathogenesis of hypertensive disease and its clinical outcomes
Aim. To identify and determine the mechanisms of an association between arterial hypertension (AH) and proatherogenic systemic metabolic disturbances in hypertensive disease (HD), as well as the possibility of eliminating these disturbances by antihypertensive therapy. Subjects and methods. Fifty-fo...
Main Authors: | V N Kovalenko, T V Talaeva, V A Shumakov, V V Bratus' |
---|---|
Format: | Article |
Language: | Russian |
Published: |
"Consilium Medicum" Publishing house
2012-11-01
|
Series: | Терапевтический архив |
Subjects: | |
Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31134 |
Similar Items
-
The role of genetic mutations in development of metabolic disturbances in patients with arterial hypertension
by: Borodulin V.B., et al.
Published: (2012-09-01) -
Atherogenic hyperadrenoreactivity in men with arterial hypertension
by: S. S. Bunova, et al.
Published: (2009-02-01) -
N-linked glycosylation of macrophage-derived PAF-AH is a major determinant of enzyme association with plasma HDL
by: Alexandros D. Tselepis, et al.
Published: (2001-10-01) -
Severity of carbohydrate metabolism disturbances, arterial hypertension stage, and lipid profile in patients with metabolic syndrome
by: Yu. V. Zhernakova, et al.
Published: (2012-04-01) -
Pharmacotherapy efficacy assessment in arterial hypertension with metabolic disturbances
by: A. A. Demin, et al.
Published: (2005-06-01)